Clinical implication of targeting of cancer stem cells.

about

The cancer stem cell hypothesis: a guide to potential molecular targets.Cancer stem cells in prostate cancer.Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies.

P2860

Q38254181-A1CF5137-E23B-4783-AD65-26903DBD2F50 Q38713728-F0173B8B-0E9B-4B69-98B5-F832A7A59E53 Q47771443-611FE7D5-4391-4ACC-BA16-EDCBB8AFA044

P2860

Clinical implication of targeting of cancer stem cells.

Item

http://www.wikidata.org/entity/Q38026464

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical implication of targeting of cancer stem cells.

@en

type

Item

label

Clinical implication of targeting of cancer stem cells.

@en

prefLabel

Clinical implication of targeting of cancer stem cells.

@en

P1476

Clinical implication of targeting of cancer stem cells.

@en

P2093

C J Bruns

http://www.w3.org/2001/XMLSchema#string

H Niess

http://www.w3.org/2001/XMLSchema#string

K-W Jauch

http://www.w3.org/2001/XMLSchema#string

L Zhao

http://www.w3.org/2001/XMLSchema#string

Q Bao

http://www.w3.org/2001/XMLSchema#string

Y Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients

Phenotypic characterization of human colorectal cancer stem cells

A functional study of miR-124 in the developing neural tube

Prospective identification of tumorigenic breast cancer cells

Cancer stem cells: relevance to clinical transplantation

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Stem cells, cancer, and cancer stem cells

P304

8-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000339610

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22797579

http://www.w3.org/2001/XMLSchema#string

Clinical implication of targeting of cancer stem cells.

about

P2860

P2860

Clinical implication of targeting of cancer stem cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698